Amanote Research

Amanote Research

    RegisterSign In

MECT1-MAML2 Fusion Transcript Defines a Favorable Subset of Mucoepidermoid Carcinoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-05-2376
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

July 1, 2006

Authors
M. Okabe
Publisher

American Association for Cancer Research (AACR)


Related search

CRTC1-MAML2 Gene Fusion in Mucoepidermoid Carcinoma of the Lacrimal Gland

Oncology Reports
MedicineCancer ResearchOncology
2012English

Primary Mucoepidermoid Carcinoma of the Liver With CRTC1-MAML2 Fusion: A Case Report

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2019English

Genomic Profiles and CRTC1–MAML2 Fusion Distinguish Different Subtypes of Mucoepidermoid Carcinoma

Modern Pathology
Forensic MedicinePathology
2012English

The MECT1-MAML2 Gene Fusion and Benign Warthin's Tumor

Journal of Molecular Diagnostics
Forensic MedicinePathologyMolecular Medicine
2006English

MAML2 Rearrangement as a Useful Diagnostic Marker Discriminating Between Warthin Tumour and Warthin-Like Mucoepidermoid Carcinoma

Virchows Archiv
MedicineForensic MedicinePathologyCell BiologyMolecular Biology
2020English

Mucoepidermoid Carcinoma

2020English

Mucoepidermoid Carcinoma

Modern Research in Dentistry
2017English

Mucoepidermoid Carcinoma of Buccal Mucosa

BMJ Case Reports
Medicine
2014English

Clinicopathological Analysis of Pulmonary Mucoepidermoid Carcinoma

World Journal of Surgical Oncology
SurgeryOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy